Fecal occult blood tests dominated the industry in 2016 owing to cost effectiveness and non-invasiveness as compared to colonoscopy and sigmoidoscopy. Immuno-FOB agglutination and Immuno-FOB ELISA tests are major revenue generating segments of fecal occult blood tests segment. Growing awareness along with rising demand for non-invasive cancer screening tests will further fuel business growth.

Scope of the Report:

Increasing incidences of colorectal cancer coupled with rising demand for non-invasive cancer screening tests will drive in-vitro colorectal cancer screening tests market over the forecast period. Growing geriatric population base, highly susceptible to suffer from colorectal cancer will further propel market growth.

The global Colorectal Cancer Diagnostic market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Colorectal Cancer Diagnostic.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

This report studies the Colorectal Cancer Diagnostic market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Colorectal Cancer Diagnostic market by product type and applications/end industries.

Market Segment by Companies, this report covers

Abbott Molecular

Alere

Beckman Coulter

Eiken Chemical

Epigenomics

Sysmex

Siemens Healthcare

Quest Diagnostics

CompanianDx

BioTime

Merck Millipore

GeneNews

BioMarCare

Immunostics

ExiQon

Mode Diagnostics

Randox

R-Biopharm

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Fecal Occult Blood Test

Biomarker Test

CRC DNA Screening Test

Market Segment by Applications, can be divided into

Hospitals

Ambulatory Surgical Centers

Diagnostic Centers

Table of Contents

1 Colorectal Cancer Diagnostic Market Overview

1.1 Product Overview and Scope of Colorectal Cancer Diagnostic

1.2 Classification of Colorectal Cancer Diagnostic by Types

1.2.1 Global Colorectal Cancer Diagnostic Revenue Comparison by Types (2017-2023)

1.2.2 Global Colorectal Cancer Diagnostic Revenue Market Share by Types in 2017

1.2.3 Fecal Occult Blood Test

1.2.4 Biomarker Test

1.2.5 CRC DNA Screening Test

1.3 Global Colorectal Cancer Diagnostic Market by Application

1.3.1 Global Colorectal Cancer Diagnostic Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Hospitals

1.3.3 Ambulatory Surgical Centers

1.3.4 Diagnostic Centers

1.4 Global Colorectal Cancer Diagnostic Market by Regions

1.4.1 Global Colorectal Cancer Diagnostic Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Colorectal Cancer Diagnostic Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Colorectal Cancer Diagnostic Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Colorectal Cancer Diagnostic Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Colorectal Cancer Diagnostic Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Colorectal Cancer Diagnostic Status and Prospect (2013-2023)

1.5 Global Market Size of Colorectal Cancer Diagnostic (2013-2023)

2 Manufacturers Profiles

2.1 Abbott Molecular

2.1.1 Business Overview

2.1.2 Colorectal Cancer Diagnostic Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Abbott Molecular Colorectal Cancer Diagnostic Revenue, Gross Margin and Market Share (2016-2017)

2.2 Alere

2.2.1 Business Overview

2.2.2 Colorectal Cancer Diagnostic Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Alere Colorectal Cancer Diagnostic Revenue, Gross Margin and Market Share (2016-2017)

2.3 Beckman Coulter

2.3.1 Business Overview

2.3.2 Colorectal Cancer Diagnostic Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Beckman Coulter Colorectal Cancer Diagnostic Revenue, Gross Margin and Market Share (2016-2017)

2.4 Eiken Chemical

2.4.1 Business Overview

2.4.2 Colorectal Cancer Diagnostic Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Eiken Chemical Colorectal Cancer Diagnostic Revenue, Gross Margin and Market Share (2016-2017)

2.5 Epigenomics

2.5.1 Business Overview

2.5.2 Colorectal Cancer Diagnostic Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Epigenomics Colorectal Cancer Diagnostic Revenue, Gross Margin and Market Share (2016-2017)

2.6 Sysmex

2.6.1 Business Overview

2.6.2 Colorectal Cancer Diagnostic Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Sysmex Colorectal Cancer Diagnostic Revenue, Gross Margin and Market Share (2016-2017)

2.7 Siemens Healthcare

2.7.1 Business Overview

2.7.2 Colorectal Cancer Diagnostic Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Siemens Healthcare Colorectal Cancer Diagnostic Revenue, Gross Margin and Market Share (2016-2017)

2.8 Quest Diagnostics

2.8.1 Business Overview

2.8.2 Colorectal Cancer Diagnostic Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Quest Diagnostics Colorectal Cancer Diagnostic Revenue, Gross Margin and Market Share (2016-2017)

2.9 CompanianDx

2.9.1 Business Overview

2.9.2 Colorectal Cancer Diagnostic Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 CompanianDx Colorectal Cancer Diagnostic Revenue, Gross Margin and Market Share (2016-2017)

2.10 BioTime

2.10.1 Business Overview

2.10.2 Colorectal Cancer Diagnostic Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 BioTime Colorectal Cancer Diagnostic Revenue, Gross Margin and Market Share (2016-2017)

2.11 Merck Millipore

2.11.1 Business Overview

2.11.2 Colorectal Cancer Diagnostic Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 Merck Millipore Colorectal Cancer Diagnostic Revenue, Gross Margin and Market Share (2016-2017)

2.12 GeneNews

2.12.1 Business Overview

2.12.2 Colorectal Cancer Diagnostic Type and Applications

2.12.2.1 Product A

2.12.2.2 Product B

2.12.3 GeneNews Colorectal Cancer Diagnostic Revenue, Gross Margin and Market Share (2016-2017)

2.13 BioMarCare

2.13.1 Business Overview

2.13.2 Colorectal Cancer Diagnostic Type and Applications

2.13.2.1 Product A

2.13.2.2 Product B

2.13.3 BioMarCare Colorectal Cancer Diagnostic Revenue, Gross Margin and Market Share (2016-2017)

2.14 Immunostics

2.14.1 Business Overview

2.14.2 Colorectal Cancer Diagnostic Type and Applications

2.14.2.1 Product A

2.14.2.2 Product B

2.14.3 Immunostics Colorectal Cancer Diagnostic Revenue, Gross Margin and Market Share (2016-2017)

2.15 ExiQon

2.15.1 Business Overview

2.15.2 Colorectal Cancer Diagnostic Type and Applications

2.15.2.1 Product A

2.15.2.2 Product B

2.15.3 ExiQon Colorectal Cancer Diagnostic Revenue, Gross Margin and Market Share (2016-2017)

2.16 Mode Diagnostics

2.16.1 Business Overview

2.16.2 Colorectal Cancer Diagnostic Type and Applications

2.16.2.1 Product A

2.16.2.2 Product B

2.16.3 Mode Diagnostics Colorectal Cancer Diagnostic Revenue, Gross Margin and Market Share (2016-2017)

2.17 Randox

2.17.1 Business Overview

2.17.2 Colorectal Cancer Diagnostic Type and Applications

2.17.2.1 Product A

2.17.2.2 Product B

2.17.3 Randox Colorectal Cancer Diagnostic Revenue, Gross Margin and Market Share (2016-2017)

2.18 R-Biopharm

2.18.1 Business Overview

2.18.2 Colorectal Cancer Diagnostic Type and Applications

2.18.2.1 Product A

2.18.2.2 Product B

2.18.3 R-Biopharm Colorectal Cancer Diagnostic Revenue, Gross Margin and Market Share (2016-2017)

3 Global Colorectal Cancer Diagnostic Market Competition, by Players

3.1 Global Colorectal Cancer Diagnostic Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Colorectal Cancer Diagnostic Players Market Share

3.2.2 Top 10 Colorectal Cancer Diagnostic Players Market Share

3.3 Market Competition Trend

4 Global Colorectal Cancer Diagnostic Market Size by Regions

4.1 Global Colorectal Cancer Diagnostic Revenue and Market Share by Regions

4.2 North America Colorectal Cancer Diagnostic Revenue and Growth Rate (2013-2018)

4.3 Europe Colorectal Cancer Diagnostic Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Colorectal Cancer Diagnostic Revenue and Growth Rate (2013-2018)

4.5 South America Colorectal Cancer Diagnostic Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Colorectal Cancer Diagnostic Revenue and Growth Rate (2013-2018)

5 North America Colorectal Cancer Diagnostic Revenue by Countries

5.1 North America Colorectal Cancer Diagnostic Revenue by Countries (2013-2018)

5.2 USA Colorectal Cancer Diagnostic Revenue and Growth Rate (2013-2018)

5.3 Canada Colorectal Cancer Diagnostic Revenue and Growth Rate (2013-2018)

5.4 Mexico Colorectal Cancer Diagnostic Revenue and Growth Rate (2013-2018)

6 Europe Colorectal Cancer Diagnostic Revenue by Countries

6.1 Europe Colorectal Cancer Diagnostic Revenue by Countries (2013-2018)

6.2 Germany Colorectal Cancer Diagnostic Revenue and Growth Rate (2013-2018)

6.3 UK Colorectal Cancer Diagnostic Revenue and Growth Rate (2013-2018)

6.4 France Colorectal Cancer Diagnostic Revenue and Growth Rate (2013-2018)

6.5 Russia Colorectal Cancer Diagnostic Revenue and Growth Rate (2013-2018)

6.6 Italy Colorectal Cancer Diagnostic Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Colorectal Cancer Diagnostic Revenue by Countries

7.1 Asia-Pacific Colorectal Cancer Diagnostic Revenue by Countries (2013-2018)

7.2 China Colorectal Cancer Diagnostic Revenue and Growth Rate (2013-2018)

7.3 Japan Colorectal Cancer Diagnostic Revenue and Growth Rate (2013-2018)

7.4 Korea Colorectal Cancer Diagnostic Revenue and Growth Rate (2013-2018)

7.5 India Colorectal Cancer Diagnostic Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Colorectal Cancer Diagnostic Revenue and Growth Rate (2013-2018)

8 South America Colorectal Cancer Diagnostic Revenue by Countries

8.1 South America Colorectal Cancer Diagnostic Revenue by Countries (2013-2018)

8.2 Brazil Colorectal Cancer Diagnostic Revenue and Growth Rate (2013-2018)

8.3 Argentina Colorectal Cancer Diagnostic Revenue and Growth Rate (2013-2018)

8.4 Colombia Colorectal Cancer Diagnostic Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Colorectal Cancer Diagnostic by Countries

9.1 Middle East and Africa Colorectal Cancer Diagnostic Revenue by Countries (2013-2018)

9.2 Saudi Arabia Colorectal Cancer Diagnostic Revenue and Growth Rate (2013-2018)

9.3 UAE Colorectal Cancer Diagnostic Revenue and Growth Rate (2013-2018)

9.4 Egypt Colorectal Cancer Diagnostic Revenue and Growth Rate (2013-2018)

9.5 Nigeria Colorectal Cancer Diagnostic Revenue and Growth Rate (2013-2018)

9.6 South Africa Colorectal Cancer Diagnostic Revenue and Growth Rate (2013-2018)

10 Global Colorectal Cancer Diagnostic Market Segment by Type

10.1 Global Colorectal Cancer Diagnostic Revenue and Market Share by Type (2013-2018)

10.2 Global Colorectal Cancer Diagnostic Market Forecast by Type (2018-2023)

10.3 Fecal Occult Blood Test Revenue Growth Rate (2013-2023)

10.4 Biomarker Test Revenue Growth Rate (2013-2023)

10.5 CRC DNA Screening Test Revenue Growth Rate (2013-2023)

11 Global Colorectal Cancer Diagnostic Market Segment by Application

11.1 Global Colorectal Cancer Diagnostic Revenue Market Share by Application (2013-2018)

11.2 Colorectal Cancer Diagnostic Market Forecast by Application (2018-2023)

11.3 Hospitals Revenue Growth (2013-2018)

11.4 Ambulatory Surgical Centers Revenue Growth (2013-2018)

11.5 Diagnostic Centers Revenue Growth (2013-2018)

12 Global Colorectal Cancer Diagnostic Market Size Forecast (2018-2023)

12.1 Global Colorectal Cancer Diagnostic Market Size Forecast (2018-2023)

12.2 Global Colorectal Cancer Diagnostic Market Forecast by Regions (2018-2023)

12.3 North America Colorectal Cancer Diagnostic Revenue Market Forecast (2018-2023)

12.4 Europe Colorectal Cancer Diagnostic Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Colorectal Cancer Diagnostic Revenue Market Forecast (2018-2023)

12.6 South America Colorectal Cancer Diagnostic Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Colorectal Cancer Diagnostic Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures

Figure Colorectal Cancer Diagnostic Picture

Table Product Specifications of Colorectal Cancer Diagnostic

Table Global Colorectal Cancer Diagnostic and Revenue (Million USD)